NYSE:CALX • US13100M5094
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CALIX INC (CALX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-30 | Needham | Maintains | Buy -> Buy |
| 2026-01-30 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-01-27 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-01-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-11-24 | Needham | Reiterate | Buy -> Buy |
| 2025-10-31 | Needham | Maintains | Buy -> Buy |
| 2025-10-31 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-15 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-22 | Needham | Maintains | Buy -> Buy |
| 2025-07-22 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-15 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-08 | Wolfe Research | Initiate | Peer Perform |
| 2025-06-12 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-04-23 | Needham | Reiterate | Buy -> Buy |
| 2025-04-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-04-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-22 | Needham | Reiterate | Buy -> Buy |
| 2025-04-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-31 | Needham | Maintains | Buy -> Buy |
| 2025-01-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-30 | Needham | Reiterate | Buy -> Buy |
| 2024-10-30 | Needham | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.04B 19.79% | 831.518M -20.02% | 1B 20.26% | 1.164B 16.40% | 1.324B 13.75% | |
| EBITDA YoY % growth | 42.216M -36.92% | -23.484M -155.63% | 38.7M 264.79% | 179.18M 363.00% | 250.07M 39.56% | |
| EBIT YoY % growth | 25.585M -51.37% | -43.034M -268.20% | 20.99M 148.78% | 154.03M 633.83% | 213.39M 38.54% | |
| Operating Margin | 2.46% | -5.18% | 2.10% | 13.23% | 16.12% | |
| EPS YoY % growth | 1.55 38.39% | 0.51 -67.10% | 1.36 166.67% | 1.84 35.04% | 2.47 34.50% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.38 99.97% | 0.43 25.50% | 0.50 14.17% | 0.51 30.12% | 0.63 66.44% | 0.61 43.43% | 0.78 54.31% | 0.74 46.73% |
| Revenue Q2Q % growth | 282.76M 28.39% | 286.95M 18.63% | 290.13M 9.30% | 296.8M 8.94% | 310.08M 9.66% | 322.83M 12.50% | 339.15M 16.90% | 354.45M 19.42% |
| EBITDA Q2Q % growth | 35.666M 2,070.50% | 40.052M 344.82% | 43.452M 41.47% | 47.124M 74.63% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 31.717M 621.58% | 35.582M 9,000.26% | 43.707M 151.12% | 44.447M 379.21% | 56.1M 76.88% | 54.06M 51.93% | 69.36M 58.69% | 66.3M 49.17% |
All data in USD
14 analysts have analysed CALX and the average price target is 72.04 USD. This implies a price increase of 38.32% is expected in the next year compared to the current price of 52.08.
CALIX INC (CALX) will report earnings on 2026-04-20.
The consensus EPS estimate for the next earnings of CALIX INC (CALX) is 0.38 USD and the consensus revenue estimate is 282.76M USD.
The number of analysts covering CALIX INC (CALX) is 14.